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by national courts, as well as national legislation. At the same time, International law should be 
used if this law contradicts core elements o f  the national legislation, according to the principle o f  
the primacy o f  International law.
Purpose and Objectives: Review the progress o f  implementation and convergence o f  
Ukraine's legislation with the current European legislation in the context o f  the European Court o f  
Human Rights judgments in Healthcare arising with non-compliance and conflicts between 
domestic and European law.
Materials and Methods: Were analyzed certain articles o f the Constitution o f Ukraine, o f  the 
Convention for the Protection o f Human Rights and Fundamental Freedoms; Law o f  Ukraine "On the 
implementation o f the decisions and practices o f the European Court o f Human Rights", the Decree o f  the 
President o f Ukraine "On Approval o f the Strategy for Ukraine's integration into the European Union."
Results: According to the Constitution o f Ukraine, the Law o f  Ukraine "On International 
Treaties and Agreements", international treaty ratified by the Verkhovna Rada o f  Ukraine is part o f  
the national legislation o f  Ukraine.
However at the end of2012 Ukraine was on a fifth place after an amount o f  the given lawsuits 
in the European court (complaints about Ukraine - 10 400 - represented 7.5% o f  the total number o f  
cases to the European Court). The main reason for complaints was the exhaustion o f  domestic 
remedies, due to inconsistency and conflict between domestic and European law.
In the practice o f  the European Court in the cases against Ukraine these issues discussed in 
the following areas:
1) Violation o f the right to protection from torture and cruel and degrading treatment.
2) Violation o f  the right to liberty and security o f  person on admission to psychiatric 
institutions.
3) Violation o f the right to fair justice.
Conclusion: Before Ukraine stands an urgent task to improve the legal base in the field o f  
health protection, to bring it to conformity with the requirements o f  International law, to reform the 
entire health care system, taking into account the fundamental principles o f  the international legal 
instruments on human rights, global politics and tendencies in health care, but adapting them to the 
political, economic and social realities o f our lives.
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Introduction: The study o f molecular mechanisms in the pathogenesis o f  cancerogenesis is 
caused by the fact that at this stage,the fight against cancerogenic pathologies has insufficient 
means o f prevention, diagnosis and treatment.We still hope that in future the tumors could be 
explained,controled and treated.
Purpose and objectives: To provide an overview o f the bibliography o f  M olecular 
Mechanisms in cancer's pathophysiology, which will serve as a point o f  initiation in the 
prophylaxis and treatment o f maligne tumors.In achieving our goal, we have to:
1. explore the role o f genes responsible for carcinogenesis;
2. find out the role o f growth factors and cellular proliferation in carcinogenesis;
3. discover the role o f apoptosis in carcinogenesis;
Materials and methods: The basis o f the research was a bibliographic review o f  the main 
work, which reveals the pathogenesis o f  carcinogenesis. The sources we used are: textbooks, 
monographs, handbooks, aplied publications, standards, patents, reports, theses, statistical freports, 
indexesand summary documentation. The stages o f study were:
l.Introduction in the topic o f the research;
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2.Researches o f  different sources;
2 .Processing and interpretation o f  selected ideas from bibliography;
Results: A proto-oncogene is a normal gene that can become an oncogene due to the 
mutations or to the increased expression. A suppressor gene o f  tumor (an antioncogene), is a gene 
that protects the cell from the first step o f  the development o f  cancer. When these mutant genes 
cause the decrease o f  their function, the cell can lead to cancer, usually in combination with other 
genetic changes. Both the activation o f  ras oncogenes and the inactivation o f  several suppressor 
genes, including p53, have been observed in the development o f  human colon and lung tumors.The 
point mutations in key codons can activate ras proto-oncogene may occur at various stages o f  the 
carcinogenetic process.The mechanisms that include impaired expression o f  proto-oncogenes are 
manifested through gene amplification and chromosomal translocation or gene rearrangement. The 
amplification o f  proto-oncogenes is usually associated to late stages o f  tum or progression. The 
apoptosis is a cellular process that occurs in physiologicaland pathological conditions. Reduced 
apoptosis or its resistance plays a vital role in carcinogenesis.There are may ways a malignant cell 
to acquire reduction in apoptosis or apoptosis resistance.Generally, the mechanisms by which 
evasion o f  apoptosis accurs can be broadly divided into:
1 .disrupted balance o f  pro-apoptotic and anti-apoptotic proteins
2.reduced caspase function
3 .impaired death o f  receptor signaling the activation o f  growth factor that signal pathways 
through genetic alterations affecting these genes, contributes to the development and progression o f  
many human cancers.The growth factors, defined as polypeptides that stimulate cell proliferation,are 
major growth-regulatory molecules for cells in culture and, probably, also for cells in vivo.The 
decreased requirement for specific growth factors is a common occurence in neoplastically 
transformed cells and can lead to a growth advantage, a cardinal feature o f  cancer cells.
Conclusion:The study o f  themolecular mechanisms o f  carcinogenesis plays a main role in the 
development o f  new methods o f  diagnosis and treatm ent o f  cancer. The molecular mechanisms 
involved in carcinogenesis serve as oncogenetic markers used in moderb techniques o f  diagnosis 
with high specificity.The drugs targeted on the elimination o f  pathological molecular mechanisms 
involved in carcinogenesis, find their place progressivly in the treatment strategies o f  cancer.
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Introduction: Experimental research on fluoxetine potent antinociceptive effects and it’s 
interactions with various opioid and adrenergic receptor derivatives, in cutaneous and visceral pain 
models were investigated.
Material and method: The experiment was carried out, with white mice (20-25g), divided 
into 7 groups o f  7 animals each, treated orally with the same volume o f  solution, for 7 days, as 
follows: Group I: distilled water 0,3ml (DW); Group II (M): metamyzole 10mg/kbw; Group III 
(FLX-10): fluoxetine 10mg/kbw; Group IV (FLX-30): fluoxetine 30mg/kbw; Group V 
(FLX+ATN): fluoxetine 30mg/kbw+atenolol lm g/kbw ; Group VI (FLX+TLZ): fluoxetine 
30mg/kbw+tolazolin lm g/kbw, Group VII (NLX+FLX): naloxone 5mg/kbw+fluoxetine 30mg/kbw. 
Hot plate was used to asses fluoxetine-induced antinociception. The model o f  visceral pain consists 
o f  writhing test using diluted acetic acid (0,6%). Data were presented as +/- standard deviation and 
significance was analyzed using SPSS for W indows version 17.0 and ANOVA method. P-values 
less than 0.05 are considered statistically significant comparing with those o f  control groups.
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